TUM012
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TUM012, covering 2024-06-04 to 2024-06-04. Get the full timeline:
Most recent: Clinical Trial Update: FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation [Phase 1, Phase 2]